Filing Details
- Accession Number:
- 0001209191-17-046232
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-07-25 18:07:23
- Reporting Period:
- 2017-07-25
- Filing Date:
- 2017-07-25
- Accepted Time:
- 2017-07-25 18:07:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1505512 | Regulus Therapeutics Inc. | RGLS | Pharmaceutical Preparations (2834) | 264738379 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1706176 | R. Daniel Chevallard | C/O Regulus Therapeutics Inc. 10614 Science Center Dr. San Diego CA 92121 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-07-25 | 54,945 | $0.91 | 59,415 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
